<DOC>
	<DOCNO>NCT00775827</DOCNO>
	<brief_summary>The study conduct open label , balance , randomise , two-treatment , two-period , two-sequence , single-dose crossover bioavailability study fenofibrate formulation compare fenofibrate 160 mg tablet Ranbaxy Laboratories Tricor 160 mg tablet healthy , adult , human subject fast condition .</brief_summary>
	<brief_title>Bioequivalency Study Fenofibrate 160mg Tablets Under Fasting Conditions</brief_title>
	<detailed_description>This open-label , randomize , single-dose , 2-way crossover , relative bioavailability study perform 40 healthy adult male subject . As per protocol , enough healthy , adult , human subject enrol study allow dose 40 subject first period . 40 subject enrol total 37 subject complete period study .</detailed_description>
	<mesh_term>Fenofibrate</mesh_term>
	<criteria>Be age range 1845 year . Be neither overweight underweight his/her height per te Life insurance Corporation india height/weight chart nonmedical case . Have voluntarily give write informed consent participate study . Be normal health determine medical history physical examination subject perform within 28 day prior commencement study . If female : Of childbearing potential , practice acceptable method birth control duration study judge investigator ( ) , condom , foam , jelly , diaphragm , intrauterine device ( IUD ) , abstinence ; TS postmenopausal least 1 year ; surgically sterile ( bilateral tubal ligation , bilateral oophorectomy , hysterectomy ) . History allergy fenofibrate relate fibric acid derivative . History gall stones/cholecystitis Any evidence organ dysfunction clinically significant deviation normal , physical clinical determination . Presence disease marker H~I 2 , Hepatitis B C viruses syphilis infection . Female volunteer demonstrate positive pregnancy screen . Female volunteer currently breasffeeding . Presence value clinically significantly different normal reference range ( define Appendix 5 ) haemoglobin , total white blood cell count , differential WBC count platelet count . Positive urinary screen test drug abuse ( opiates cannabinoids ) Presence value significantly different normal reference range ( define Appendix 5 ) serum creatinine , blood urea nitrogen , serum aspartate aminotransferase ( AST ) , serum alanine aminotransferase ( ALT ) , serum alkaline phosphatase , serum bilirubin , plasma glucose , serum cholesterol serum triglyceride . Clinically abnormal chemical microscopic examination urine define presence .of RBC , WBC ( &gt; 4/HPF ) , epithelial cell ( &gt; 4/HPF ) , glucose ( positive ) protein ( positive ) . Clinically abnormal ECG Chest Xray . History serious gastrointestinal , hepatic , renal , cardiovascular , pulmonary , neurological haematological disease , diabetes glaucoma . History psychiatric illness may impair ability provide write informed consent . Regular smoker smoke 10 cigarette daily difficulty abstain smoke duration study period . History drug dependence excessive alcohol intake habitual basis 2 unit alcoholic beverage per day ( ! Unit equivalent half pint beer 1 glass wine 1 measure spirit ) difficulty abstain the'duration study period . Use enzyme modifying drug within 30 day prior Day 1 study . Participation clinical trial within 6 week precede Day ! study . Subjects , completion study , would donate and/or lose 35 ; 0 mL blood past 3 month .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>bioequivalence fenofibrate tablet</keyword>
</DOC>